<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.2" xml:lang="ru" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="issn">2658-6533</journal-id><journal-title-group><journal-title>Научные результаты биомедицинских исследований</journal-title></journal-title-group><issn pub-type="epub">2658-6533</issn></journal-meta><article-meta><article-id pub-id-type="doi">10.18413/2658-6533-2026-12-2-0-1</article-id><article-id pub-id-type="publisher-id">4151</article-id><article-categories><subj-group subj-group-type="heading"><subject>Генетика</subject></subj-group></article-categories><title-group><article-title>&lt;strong&gt;Clinical characterization of a child with &lt;em&gt;de novo&lt;/em&gt; partial trisomy 9p24-9q12&lt;/strong&gt;</article-title><trans-title-group xml:lang="en"><trans-title>&lt;strong&gt;Clinical characterization of a child with &lt;em&gt;de novo&lt;/em&gt; partial trisomy 9p24-9q12&lt;/strong&gt;</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>García-García</surname><given-names>Alina</given-names></name><name xml:lang="en"><surname>García-García</surname><given-names>Alina</given-names></name></name-alternatives><email>alinagg@infomed.sld.cu</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Galarza</surname><given-names>Juan E.</given-names></name><name xml:lang="en"><surname>Galarza</surname><given-names>Juan E.</given-names></name></name-alternatives><email>juaneligb@yahoo.es</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Castelví</surname><given-names>Arlay</given-names></name><name xml:lang="en"><surname>Castelví</surname><given-names>Arlay</given-names></name></name-alternatives><email>arlay@cngen.sld.cu</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Barrios-Martínez</surname><given-names>Anduriña</given-names></name><name xml:lang="en"><surname>Barrios-Martínez</surname><given-names>Anduriña</given-names></name></name-alternatives><email>abarrios@cngm.sld.cu</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Morales-Peralta</surname><given-names>Estela</given-names></name><name xml:lang="en"><surname>Morales-Peralta</surname><given-names>Estela</given-names></name></name-alternatives><email>fornaris@infomed.sld.cu</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Soriano-Torres</surname><given-names>Michel</given-names></name><name xml:lang="en"><surname>Soriano-Torres</surname><given-names>Michel</given-names></name></name-alternatives><email>michel.soriano@cngen.sld.cu</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Méndez-Rosado</surname><given-names>Luis A.</given-names></name><name xml:lang="en"><surname>Méndez-Rosado</surname><given-names>Luis A.</given-names></name></name-alternatives><email>albermen@infomed.sld.cu</email></contrib></contrib-group><pub-date pub-type="epub"><year>2026</year></pub-date><volume>12</volume><issue>2</issue><fpage>0</fpage><lpage>0</lpage><self-uri content-type="pdf" xlink:href="/media/medicine/2026/2/Биомедисследования-6-13.pdf" /><abstract xml:lang="ru"><p>Background: Partial trisomy 9p is considered the fourth most frequently reported trisomy in live births, following trisomies 21, 18, and 13. This relatively high incidence is observed, probably, due to the limited number of genes involved within the 9p24-9q12 region. With a frequency of less than 1 in 1,000,000 live births, it is classified as a rare disease. The aim of the study: To describe the phenotypic characteristics of a child with de novo partial trisomy 9p and compare them with previously documented cases in the international literature. Materials and methods: A descriptive case report of a 4-year-old male patient with global neurodevelopmental delay and dysmorphic features evaluated at the William Soler University Pediatric Hospital. Clinical, anthropometric, dermatoglyphic, imaging (computed tomography, echocardiography, ultrasound), and audiometric (brainstem auditory evoked potentials) assessments were carried out. Cytogenetic analysis was performed on peripheral blood lymphocyte cultures using the synchronization method, with high-resolution GTG-banded karyotyping. Fluorescence in situ hybridization (FISH) was used to characterize the supernumerary chromosome with VYSIS (Abbott) probes. The clinical and cytogenetic findings were compared with previously published cases. Results: A 4-year-old male patient presented with global neurodevelopmental delay and distinctive facial dysmorphisms. At birth, he exhibited cyanosis and an absence of the crying and sucking reflexes. He was subsequently noted to have severe neurodevelopmental delay from the first month of life, and initially presented with hypotonia, which improved following physical therapy. His social development was poor, and language development was nearly non-existent. Physical examination revealed low height and weight for his age, alongside multiple facial dysmorphic features. He was also diagnosed with a Dandy-Walker malformation, pulmonary valve dysplasia, and an 8 mm atrial septal defect. Karyotyping identified a large supernumerary chromosome, which, via GTG banding, was characterized as partial trisomy 9p, consistent with the chromosomal formula: 47,XY,+del(9)(q12q34.3). Cytogenetic analysis of both parents showed a normal constitution. Conclusion: The patient&amp;#39;s clinical findings were consistent with those reported in the literature, which, in conjunction with conventional cytogenetic studies, led to the diagnosis of de novo partial trisomy 9p</p></abstract><trans-abstract xml:lang="en"><p>Background: Partial trisomy 9p is considered the fourth most frequently reported trisomy in live births, following trisomies 21, 18, and 13. This relatively high incidence is observed, probably, due to the limited number of genes involved within the 9p24-9q12 region. With a frequency of less than 1 in 1,000,000 live births, it is classified as a rare disease. The aim of the study: To describe the phenotypic characteristics of a child with de novo partial trisomy 9p and compare them with previously documented cases in the international literature. Materials and methods: A descriptive case report of a 4-year-old male patient with global neurodevelopmental delay and dysmorphic features evaluated at the William Soler University Pediatric Hospital. Clinical, anthropometric, dermatoglyphic, imaging (computed tomography, echocardiography, ultrasound), and audiometric (brainstem auditory evoked potentials) assessments were carried out. Cytogenetic analysis was performed on peripheral blood lymphocyte cultures using the synchronization method, with high-resolution GTG-banded karyotyping. Fluorescence in situ hybridization (FISH) was used to characterize the supernumerary chromosome with VYSIS (Abbott) probes. The clinical and cytogenetic findings were compared with previously published cases. Results: A 4-year-old male patient presented with global neurodevelopmental delay and distinctive facial dysmorphisms. At birth, he exhibited cyanosis and an absence of the crying and sucking reflexes. He was subsequently noted to have severe neurodevelopmental delay from the first month of life, and initially presented with hypotonia, which improved following physical therapy. His social development was poor, and language development was nearly non-existent. Physical examination revealed low height and weight for his age, alongside multiple facial dysmorphic features. He was also diagnosed with a Dandy-Walker malformation, pulmonary valve dysplasia, and an 8 mm atrial septal defect. Karyotyping identified a large supernumerary chromosome, which, via GTG banding, was characterized as partial trisomy 9p, consistent with the chromosomal formula: 47,XY,+del(9)(q12q34.3). Cytogenetic analysis of both parents showed a normal constitution. Conclusion: The patient&amp;#39;s clinical findings were consistent with those reported in the literature, which, in conjunction with conventional cytogenetic studies, led to the diagnosis of de novo partial trisomy 9p</p></trans-abstract><kwd-group xml:lang="ru"><kwd>Karyotype</kwd><kwd>Trisomy</kwd><kwd>Neurodevelopmental Disorders</kwd><kwd>Rare Diseases</kwd><kwd>Chromosomes</kwd><kwd>Human</kwd><kwd>Pair 9</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Karyotype</kwd><kwd>Trisomy</kwd><kwd>Neurodevelopmental Disorders</kwd><kwd>Rare Diseases</kwd><kwd>Chromosomes</kwd><kwd>Human</kwd><kwd>Pair 9</kwd></kwd-group></article-meta></front><back><ref-list><title>Список литературы</title><ref id="B1"><mixed-citation>Trisomy 9p syndrome [Internet]. Orphanet [cited 2025 Dec 8]. Available from:&amp;nbsp; https://www.orpha.net/en/disease/detail/236</mixed-citation></ref><ref id="B2"><mixed-citation>Jones KL, Jones MC, Del Campo M. Smith&amp;rsquo;s Recognizable Patterns of Human Malformation. 8a ed. Philadelphia: Elsevier; 2021.</mixed-citation></ref><ref id="B3"><mixed-citation>Sams EI, Ng JK, Tate V, et al. From karyotypes to precision genomics in 9p deletion and duplication syndromes. Human Genetics and Genomics Advances. 2022;3(1):100081. DOI: https://doi.org/10.1016/j.xhgg.2021.100081</mixed-citation></ref><ref id="B4"><mixed-citation>Cammarata-Scalisi F. Trisomy 9p. A brief clinical, diagnostic and therapeutic description. Archivos Argentinos de Pediatria. 2019;117(5):e473-476. DOI: https://doi.org/10.5546/aap.2019.eng.e473</mixed-citation></ref><ref id="B5"><mixed-citation>Moczulska H, Pietrusinski M, Zezawska K, et al. Cases of tetrasomy 9p and trisomy 9p in prenatal diagnosis-Analysis of noninvasive and invasive test results. Frontiers in Genetics. 2022;13:994455. DOI: https://doi.org/10.3389/fgene.2022.994455</mixed-citation></ref><ref id="B6"><mixed-citation>Teraoka M, Narahara K, Yokoyama Y, et al. Maternal origin of a unique extra chromosome, der(9)(pter--&amp;gt;q13::q13--&amp;gt;q12:) in a girl with typical trisomy 9p syndrome. American Journal of Medical Genetics. 2001;102(1):25-28. DOI: https://doi.org/10.1002/1096-8628(20010722)102:1&amp;lt;25::aid-ajmg1399&amp;gt;3.0.co;2-b</mixed-citation></ref><ref id="B7"><mixed-citation>Franchi PG, Calabrese G, Morizio E, et al. FISH analysis in detecting 9p duplication (p22p24). American Journal of Medical Genetics. 2000;90(1):35-37. DOI: https://doi.org/10.1002/(sici)1096-8628(20000103)90:1&amp;lt;35::aid-ajmg7&amp;gt;3.0.co;2-x</mixed-citation></ref><ref id="B8"><mixed-citation>Willatt LR, Barber JCK, Clarkson A, et al. Novel deletion variants of 9q13-q21.12 and classical euchromatic variants of 9q12/qh involve deletion, duplication and triplication of large tracts of segmentally duplicated pericentromeric euchromatin. European Journal of Human Genetics. 2007;15(1):45-52. DOI: https://doi.org/10.1038/sj.ejhg.5201720</mixed-citation></ref><ref id="B9"><mixed-citation>&amp;Aacute;lvarez YB, Mart&amp;iacute;nez AB, Rodr&amp;iacute;guez EM, et al. Unusual gain in 9qh and its possible influence on reproductive disorders. A case report. Health, Science and Technology - Lecture Series. 2022;2(3):339. Spanish. DOI: https://doi.org/10.56294/sctconf2023339</mixed-citation></ref><ref id="B10"><mixed-citation>Wright CA, Scheuerle AE, Wilson K, et al. Phenotypic and genotypic insights into concurrent tertiary trisomy for 9p and 18p. Molecular Cytogenetics. 2025;18(1):1. DOI: https://doi.org/10.1186/s13039-025-00704-9</mixed-citation></ref><ref id="B11"><mixed-citation>McKusick-Nathans Institute of Genetic Medicine JHU (Baltimore MD). Online Mendelian Inheritance in Man, OMIM&amp;reg; [Internet]. 2021 [cited 2025 Dec 8]. Available from: https://omim.org/</mixed-citation></ref><ref id="B12"><mixed-citation>MIM # 600195: Venous malformations, multiple cutaneous and mucosaL; VMCM [Internet]. Online Mendelian Inheritance in Man, OMIM&amp;reg;. Johns Hopkins University, Baltimore, MD. 2022 [cited 2023 Jun 26]. Available from: https://omim.org</mixed-citation></ref><ref id="B13"><mixed-citation>MIM #618286: Macrocephaly, acquired, with impaired intellectual developmentT; MACID [Internet]. Online Mendelian Inheritance in Man, OMIM&amp;reg;. Johns Hopkins University, Baltimore, MD. 2022 [cited 2023 Dec 8]. Available from: https://omim.org</mixed-citation></ref><ref id="B14"><mixed-citation>MIM # 616255: Short stature with nonspecific skeletal abnormalities 1; SNSK1 [Internet]. Online Mendelian Inheritance in Man, OMIM&amp;reg;. Johns Hopkins University, Baltimore, MD. 2022 cited 2023 Jun 26]. Available from: https://omim.org</mixed-citation></ref><ref id="B15"><mixed-citation>Guilherme RS, Meloni VA, Perez ABA, et al. Duplication 9p and their implication to phenotype. BMC Medical Genetics. 2014;15:142. DOI: https://doi.org/10.1186/s12881-014-0142-1</mixed-citation></ref><ref id="B16"><mixed-citation>Tsezou A, Kitsiou S, Galla A, et al. Molecular cytogenetic characterization and origin of two de novo duplication 9p cases. American Journal of Medical Genetics. 2000;91(2):102-106. DOI: https://doi.org/10.1002/(sici)1096-8628(20000313)91:2&amp;lt;102::aid-ajmg4&amp;gt;3.0.co;2-5</mixed-citation></ref><ref id="B17"><mixed-citation>Chen CP, Chang TY, Shih JC, et al. Prenatal diagnosis of the Dandy-Walker malformation and ventriculomegaly associated with partial trisomy 9p and distal 12p deletion. Prenatal Diagnosis. 2002;22(12):1063-1066. DOI: https://doi.org/10.1002/pd.459</mixed-citation></ref><ref id="B18"><mixed-citation>Kuan CY, Tai CJ, Shyu IL, et al. A de novo partial trisomy 9p with Dandy-Walker malformation and ventriculomegaly. Taiwanese Journal of Obstetrics and Gynecology. 2022;61(6):1077-1081. DOI: https://doi.org/10.1016/j.tjog.2022.05.018</mixed-citation></ref></ref-list></back></article>